Klotz, L. et al. 2017. Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer. Canadian Urological Association Journal. 11, 1-2 (Feb. 2017), 16–23. DOI:https://doi.org/10.5489/cuaj.4303.